Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationRequest/medrx0311 (Narrative)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationRequest.

Generated Narrative: MedicationRequest

Resource MedicationRequest "medrx0311"

identifier: id: 12345689 (use: OFFICIAL)

status: active

intent: order

Medications

-Reference
*

code: Chlorthalidone 50mg tablet (product) (SNOMED CT#317935006)

doseForm: Tablet dose form (qualifier value) (SNOMED CT#385055001)

subject: Patient/pat1: Donald Duck "Donald DUCK"

encounter: Encounter/f001: encounter who leads to this prescription

authoredOn: 2015-01-15

requester: Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

-Reference
*Condition/f201: condition for prescribing this medication

note: Chlorthalidone increases urniation so take it in the morning

dosageInstruction

sequence: 1

text: One tablet daily

additionalInstruction: With or after food (SNOMED CT#311504000)

timing: Code: QD

route: Oral Route (SNOMED CT#26643006)

method: Swallow - dosing instruction imperative (qualifier value) (SNOMED CT#421521009)

doseAndRate

dispenseRequest

validityPeriod: 2015-01-15 --> 2016-01-15

numberOfRepeatsAllowed: 1

quantity: 30 TAB (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet')

ExpectedSupplyDurations

-ValueUnitSystemCode
*30daysUnified Code for Units of Measure (UCUM)d

Substitutions

-Allowed[x]Reason
*truecontinuing therapy (ActReason#CT)

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.